Anesthetic Techniques in EP Patients
Launched by UNIVERSITY OF CALIFORNIA, LOS ANGELES · Jan 22, 2016
Trial Information
Current as of June 24, 2025
Terminated
Keywords
ClinConnect Summary
Anesthetic management in patients coming for electrophysiology procedures is extremely important and hemodynamically challenging in order to minimize interference on the electrophysiology studies (EPS) and the ability to trigger arrhythmias while also maintaining patient comfort and limited movement. Various anesthetic combinations are administered to provide sedation, analgesia/sedation, or general anesthesia. The ideal agent should produce rapid loss of consciousness while ensuring cardiovascular stability and prompt recovery with few adverse effects. Our goal is to study anesthetic techn...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients scheduled for cardiac electrophysiology procedures
- • Patients ≥18 years of age
- Exclusion Criteria:
- • Gastroesophageal reflux disease (GERD),
- • pulmonary hypertension,
- • severe pulmonary disease,
- • obstructive sleep apnea (OSA) with continuous positive airway pressure therapy (CPAP)
About University Of California, Los Angeles
The University of California, Los Angeles (UCLA) is a prestigious academic institution renowned for its commitment to research and innovation in the biomedical field. As a clinical trial sponsor, UCLA leverages its cutting-edge facilities, expert faculty, and collaborative environment to advance medical knowledge and improve patient care. The university is dedicated to conducting rigorous clinical research that adheres to the highest ethical standards, aiming to translate scientific discoveries into effective therapies and interventions. Through its diverse array of clinical trials, UCLA seeks to address critical health challenges while fostering the development of future healthcare leaders.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Los Angeles, California, United States
Patients applied
Trial Officials
Aman Mahajan, MD, PhD
Principal Investigator
University of California, Los Angeles
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials